Monoclonal antibodies were used to study antigenic variation in the nucleoprotein of influenza A viruses. We found that the nucleoprotein molecule of the WSN/33 strain possesses at least five different determinants. Viruses of other influenza A virus subtypes showed antigenic variation in these nucleoprotein determinants, although changes in only one determinant were detected in HON1 and animal strains. The nucleoprotein of human strains isolated from 1933 through 1979 could be divided into six groups, based on their reactivities with monoclonal antibodies; these groups did not correlate with any particular hemagglutinin or neuraminidase subtype. Our results indicate that antigenic variation in the nucleoproteins of influenza A viruses proceeds independently of changes in the viral surface antigens and suggest that point mutations and genetic reassortment may account for nucleoprotein variability.
The three types of influenza viruses (types A, B, and C) are distinguished by the lack of serological cross-reactivity among the type-specific antigens of their internally located matrix proteins and nucleoproteins (NP). Type A influenza viruses are classified further into antigenic subtypes on the basis of the antigenic relatedness of their highly variable surface proteins, hemagglutinin and neuraminidase (4) . Initial complement fixation and immunodiffusion tests indicated that the NP and matrix proteins of influenza A viruses are antigenically stable (18, 20) . However, reports of differing electrophoretic migration rates of NP (1, 13, 14) and of RNA segments coding for NP (15) in polyacrylamide gels and reports of differences in the oligonucleotide maps of these NP genes (25) from different influenza A strains indicate that mutations occur in the genetic information for the NP. Until recently however, the only evidence that these mutations may be reflected in antigenic alterations in NP molecules was a report that slight differences among influenza A virus NP could be detected by modified complement fixation tests (5) .
The first direct evidence for antigenic variation in the NP was reported by Schild et al. (19) . Using To examine antigenic variation in NP more precisely, we tested homogeneous monoclonal antibodies to NP in enzyme-linked immunosorbent assays (EIA) with human and "animal" influenza strains isolated between 1933 and 1979. Monoclonal antibodies are highly specific reagents capable of detecting a single amino acid change in a determinant (10) , and the sensitivity of the EIA is on the order of that of a radioimmunoassay (7) . Using these powerful methods in combination, we showed that the WSN/33 (HON1) influenza virus NP possesses at least five distinct antigenic determinants and that variation in some of these determinants has occurred in other influenza A strains.
MATERIALS AND METHODS
Viruses. Reference strains of the HON1, HlNl, H2N2, and H3N2 human subtypes and some representative animal strains were used (see Table 2 ). The production of recombinant strains (see Table 3 ) followed published procedures (23) . Viruses were grown in the allantoic cavities of 10-day-old embryonated hen eggs, concentrated by adsorption to and elution from chicken erythrocytes, and purified by banding in sucrose gradients, as previously described (11) . the 8-azaquanine-resistant clone of MOPC-21 myeloma cells (P3/X63-Ag8), using polyethylene glycol (8) . The culture fluids were tested for antibody by hemagglutination inhibition and neuraminidase inhibition tests, using as antigen a clone of WSN virus selected for inhibitor resistance (24) , and by EIA using purified WSN virus. The specificity of hybridomas negative in the hemagglutination inhibition and neuraminidase inhibition tests but positive in the EIA was determined by radio-immunoprecipitation assays. Hybridomas producing antibodies which specifically precipitated the NP were cloned in soft agar.
Serological assays. Hemagglutinin inhibition and neuraminidase inhibition tests were performed as described previously (2, 6) . Indirect EIA were performed by the method of Ruitenberg et al. (17) , with the following modifications. Purified influenza virus in lysis buffer (0.5 M Tris-hydrochloride buffer, pH 7.5, containing 0.5% Triton X-100 and 0.6 M KCI) was adsorbed to polystyrene multiwell dishes (15 , The gels were processed for fluorography and exposed to Kodak XR-5 film for 20 h. RESULTS Specificities of the monoclonal antibodies. Hybridomas produced by fusion of myeloma cells with splenic lymphocytes from mice immunized with WSN virions might produce antibodies to any one of the viral proteins. Therefore, it was necessary to identify the cultures producing antibodies specific for the NP. A preliminary screening of the culture supernatants by hemagglutination inhibition and neuraminidase inhibition tests eliminated those supernatants reacting with the viral surface proteins. Supernatants which were negative by the hemagglutination inhibition and neuraminidase inhibition tests were screened for reactivity with internal viral components by ETA, using detergent-lysed WSN virions. The specificities of these antibodies to internal proteins were determined by radio-immunoprecipitation and polyacrylamide gel electrophoresis analysis of the precipitates. In several precipitates there was a protein which comigrated with the NP band of marker virus. For undetermined reasons the influenza virus NP migrated as a doublet, as observed by others (16) . Figure 1 shows the migration profile of WSN viral proteins (Fig. 1, lane  1) and the specific precipitation of the NP by five monoclonal antibodies (lanes 2 through 6). To rule out the possibility that the antibodies were directed toward one of the viral polymerase proteins, resulting in co-precipitation of the NP, these antibodies were tested in in vitro polymerase inhibition assays (21) (data not shown). It has been demonstrated that influenza virus polymerase activity is not inhibited by antibodies to the NP (21) . None of our monoclonal antibodies inhibited the WSN/33 virus polymerase, confirming their specificities for the NP as determined by the immunoprecipitation assay. A total of 11 hybridomas producing anti-NP antibodies were identified in this manner. These cultures were cloned and used in subsequent experiments.
Monoclonal antibodies directed toward different antigenic determinants on the NP.
To determine whether the monoclonal antibodies were directed toward the same or different antigenic determinants on the NP molecule, they were tested in EIA ( Swine/Iowa/30 a Surface antigen subtypes were determined by hemagglutination inhibition and neuraminidase inhibition tests with reference antisera.
b +, Optical density at 405 nm threefold higher than the optical density at 405 nm of a P3/X63-Ag8 culture supernatant in EIA; -, optical density at 405 nm less than twice the optical density at 405 nm of a P3/X63-Ag8 culture supernatant in EIA.
c The recombinant produced from Hong Kong/1/68 and PR/8/34 has been designated X-31. ble 3). These results indicate that the PR/8/34 (HON1) parent contributed the NP gene to the X-31 recombinant, confirming the RNA analysis of X-31 (22) . The other strains examined were known to be surface antigen recombinants, but the parental donor of the NP gene was unknown. By comparing the reactivity patterns of the parental viruses with those of the recombinants (Table 3) , we were able in every case to unambiguously identify the parental donor of the NP gene. These results illustrate the usefulness of monoclonal antibodies for antigenic characterization of new strains of influenza viruses. DISCUSSION In contrast to the highly variable surface proteins, the influenza NP was characterized originally as antigenically invariant (20) . Since the NP is located internally in the virion and antibodies to the NP do not neutralize virus infectivity, the apparent antigenic stability of this molecule seemed reasonable; it would not be exposed to immune selection pressure. Our results, however, clearly demonstrate that antigenic variation does occur in the influenza virus NP. We produced five monoclonal antibodies, each of which reacts with a different NP determinant. The topographical location on the NP molecule of the determinants defined by these five monoclonal antibodies and the fraction of the total complement of NP antigenic sites which they represent are not known. However, it appears that one of the epitopes must be present on a region of the NP molecule which has been conserved in every influenza A virus strain examined and may be necessary for either the functional or structural integrity of the molecule. This particular epitope, which is identical in human and animal strains circulating during the past 45 years, may be a type-specific determinant for influenza A viruses.
In addition to the invariant type-specific determinant, we found four other NP epitopes which differ antigenically. Monoclonal antibodies to these epitopes detected a minor amount of variation in the animal strains and human HON1 influenza A viruses. In these strains variation was limited to only one of the five determinants; the other determinants were indistinguishable from the WSN strain. In contrast, the HlNl, H2N2, and H3N2 viruses showed more extensive alterations in their NP determinants. For example, four of the five NP epitopes of the WSN/33 strain have not been conserved in the USSR/90/77 strain.
Based on their reactivity with the monoclonal antibodies, all of the strains tested fell into six NP epitope groups (Table 4) . Since the only NP alterations detected were those affecting five antibody-binding sites, the antigenic similarities among the viruses may be restricted to a minor, but variable, portion of the NP and do not necessarily reflect the total homologies among the NP genes of strains within an NP group. Antigenic variation in the NP appears to proceed independently of major antigenic changes in the hemagglutinin and neuraminidase. The NP epitope groups do not correlate with any particular hemagglutinin or neuraminidase subtype; most NP epitope groups are composed of strains rep- (26) . The mechanism of genetic reassortment provides a reasonable explanation for the close antigenic similarity between the California/10/78 (HlNl) NP and the Texas/1/77 (H3N2) NP. An alternative mechanism for antigenic variation in the influenza virus NP is point mutations in the NP gene. The minor amount of antigenic variation detected among the HON1 strains (groups I, II, and III) could be due to different point mutations in the NP gene. However, this is probably not the sole mechanism operative in NP variability, since it is unlikely that strains isolated during a period of 25 years (group IV) would have independently undergone identical point mutations resulting in NP indistinguishable at the five epitopes examined.
The data reported here suggest that both point mutations and genetic reassortment contribute to antigenic variation in influenza A virus NP, as in the hemagglutinin and neuraminidase. The selective advantage ofinfluenza viruses with altered NP antigens is not known. However, since the NP is intimately involved in the viral replication complex and has been associated with virulence characteristics of the virus (3), alterations in this molecule may affect important biological properties, such as viral replication, transmission, and virulence. Some changes could provide a survival advantage in nature and could explain why strains circulating early in the H3N2 era, e.g. Aichi/2/68 (group V) and Hong Kong/1/68 (group III), were replaced by H3N2 strains of group IV. This also may account for the recent emergence of the recombinant HlNl strain California/10/78, which has apparently derived its NP and polymerase genes from a group IV H3N2 virus, Texas/1/77 (26 
